Skip to main content
. 2013 Nov;51(11):3666–3674. doi: 10.1128/JCM.01669-13

Table 2.

Concordance between population sequencing and the MAS assay in DR mutation genotyping of patient specimens (n = 148) at each resistance mutation site

pol region Position No. (%) of alleles detected No. (%) of specimens with concordant resultsa No. of discrepancies No. of additional mixturesb
rt 41 145 (97.97) 144 (99.31) 1 0
65 148 (100.0) 145 (97.97) 3 3
70 142 (95.95) 141 (99.30) 1 1
74 144 (97.30) 144 (100.0) 0 0
115 145 (97.97) 145 (100.0) 0 0
151 143 (96.62) 143 (100.0) 0 0
184 137 (92.57) 134 (97.81) 3 2
219 142 (95.95) 141 (99.30) 1 0
100 143 (96.62) 143 (100.0) 0 0
101c 147 (99.32) 143 (97.28) 4 2
103 146 (98.65) 139 (95.21) 7 5
106 148 (100.0) 146 (98.65) 2 2
181c 137 (92.57) 135 (98.54) 2 1
188c 143 (96.62) 141 (98.60) 2 2
190c 145 (97.97) 140 (96.55) 5 5
prt 32 148 (100.0) 148 (100.0) 0 0
47 148 (100.0) 148 (100.0) 0 0
76 140 (94.59) 140 (100.0) 0 0
84 148 (100.0) 148 (100.0) 0 0
90 148 (100.0) 147 (99.32) 1 1
Total 2,887 (97.53) 2,855 (98.89) 32 24
a

The concordance rate equals the number of concordant specimens divided by the number of alleles detected.

b

Number of additional mixtures detected by the MAS assay.

c

Six untargeted alleles at four loci could not be detected because no ASPE primers were designed for them; these include one K101Q, Y181I, Y188H, G190S, and two Y188C.